Dr. Arora on the Evolving Treatment Landscape in Multiple Myeloma

In Partnership With:

Shagun Arora, MD, discusses the rapidly advancing multiple myeloma treatment landscape.

Shagun Arora, MD, assistant clinical professor, Division of Hematology/Oncology, University of California, San Francisco, ​Helen Diller Family Comprehensive Cancer Center, discusses the rapidly advancing multiple myeloma treatment landscape.

The armamentarium in multiple myeloma has changed significantly in recent years with the approvals of several triplet regimens, says Arora.​ Moreover, triplet regimens should be utilized when possible to deepen remissions and prolong progression-free survival.

With a number of encouraging therapies in the pipeline, future research efforts should focus on identifying the optimal sequencing strategy for these patients​, Arora explains.

Moreover, factors such as comorbidities and quality of life should be kept in mind during treatment selection, Arora concludes. 

Related Videos
Brian A. Van Tine, MD, PhD
Jason Luke, MD, FACP
Katherine B. Peters, MD, PhD
Yasushi Goto, MD
Prithviraj Bose, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Jun Ma, MD
Hussein A. Tawbi, MD, PhD
Katsumori Asai, MD, PhD
Bernard Doger de Spéville, MD, PhD
Related Content